Akèy › Gliyòm › New York › New York City
Etid klinik pou Gliyòm nan New York City, NY
25 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, New York
- Research Site, New York
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Ap rekriteFaz 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Columbia University Irving Medical Center, New York
A Study of Mirdametinib in People With Central Nervous System Tumors
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- ak 1 plis
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Ap rekriteFaz 1
- New York University, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Ap rekriteFaz 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Ap rekriteFaz 1
- NYU Langone Health, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Ap rekrite
- NYU Langone Health, New York
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
Ap rekriteFaz 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of 177Lu-PSMA-617 in People With Gliomas
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Ap rekriteFaz 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Ap rekrite
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Ap rekrite
- Lenox Hill Brain Tumor Center, New York
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Ap rekriteFaz 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- Memorial Slone Kettering Cancer Center, New York
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Ap rekriteFaz 1
- Memorial Sloan Kettering, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Ap rekriteFaz 2
- Lenox Hill Brain Tumor Center, New York
FUS Etoposide for DMG
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
Ap rekriteFaz 1 bonè
- NYU Langone Health, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
Etid Gliyòm nan lòt vil
- Houston, TX23 etid
- Boston, MA20 etid
- Washington, DC19 etid
- Philadelphia, PA16 etid
- Columbus, OH15 etid
- Miami, FL15 etid
- San Francisco, CA14 etid
- Chicago, IL13 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- St. Louis, MO10 etid
- Aurora, CO10 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.